Abraham Acevedo
@Acevedo_lab
almost (neuro)scientist
Job alert 🚨 Fully funded PhD position associated with a project (FPI) focused on the study of the central role of TDP-43 in ALS. We are looking for enthusiastic people interested in the study of molecular mechanisms of neurodegeneration using innovative mouse models.
🔴 El Consejo de Ministros aprueba la ayuda directa para garantizar cuidados profesionales 24 horas a pacientes con ELA en fase avanzada. Incluyen manejo de ventilación asistida, control de secreciones, apoyo en cuidados básicos, coordinación médica y atención al proyecto vital.
💥 A gut microbe metabolite that drives #atherosclerosis? Yes—Imidazole propionate (ImP) triggers vascular inflammation without changing cholesterol. 🧪 We show the pathway—and how to block it. nature.com/articles/s4158… #OpenAccess at @Nature @CNIC_CARDIO #microbiome #CVD
El 31 de octubre será un día clave para la #LeyELA: se presenta el plan de despliegue ante las CCAA. Esperamos 👉 Que, por fin, se dote de recursos a la Ley‼️ La #ELA avanza, pero las ayudas no llegan. Confiamos en que esta vez sí se garantice el apoyo que miles de personas…
Job alert!! Postdoctoral position (3 years) available soon in our lab in Tenerife to study immunity and cell signalling in neurodegeneration using mouse models. If you are interested, please email me with a CV and motivation letter: [email protected]
📷 Thrilled to share that we've got a #CaixaResearch Grant! Super excited to start working w/amazing collaborators @Acevedo_lab (#FIISC) and @cabimer colleague @danielrico_bio @CSIC. Stay tuned, we'll all be recruiting postdocs soon! @unisevilla
We are hiring !!! @sauralab is looking for a very motivated postdoc to investigate the role of parvalbumin interneurons in neural circuits dysfunction in #Alzheimer’s disease.Leaded by Dr A.Parra & @CarlesSaura Please spread !!! euraxess.ec.europa.eu/jobs/289140
Delighted to share our latest paper 'Severe dynein dysfunction in cholinergic neurons exacerbates ALS-like phenotypes in a new mouse model'. Read at doi.org/10.1016/j.bbad… Funded by MND Association @mndassoc
Researchers at @UCLIoN and @TheCrick have developed a groundbreaking new approach to selectively target diseased cells in motor neuron disease, potentially leading to safer and more effective treatments. #MND @ScienceMagazine bit.ly/3Yevo2j
Our paper on cryptic splicing-controlled protein expression, which we hope will inspire safer and more adventurous gene therapy approaches for ALS and FTD, has been published in @ScienceMagazine science.org/doi/10.1126/sc…